NCT02565862View on ClinicalTrials.gov

A Drug-drug Interaction Study Between Daclatasvir and Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Hepatitis CDiabetes MellitusInsulin Resistance
Interventions
DRUG

Daclatasvir

DRUG

Metformin

Trial Locations (1)

Unknown

CRCN, Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02565862 - A Drug-drug Interaction Study Between Daclatasvir and Metformin | Biotech Hunter | Biotech Hunter